How Ph.D. was paid
$1.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Other | Total |
|---|---|---|---|---|---|---|
| Mark Litton, Ph.D.President and Chief Executive Officer | $625,000 | $171,875 | $83,720 | $518,135 | $25,085 | $1,423,814 |
| Javier San Martin, M.D.Chief Medical Officer | $500,000 | $100,000 | $27,907 | $182,143 | $85 | $810,134 |
| Mark WorthingtonGeneral Counsel, Chief Compliance Officer and Corporate Secretary | $450,000 | $90,000 | $21,541 | $140,601 | $29,335 | $731,477 |
What changed and why
- $1.42M$1.42 million: CEO total compensation fell from $3.18 million in 2024.
- $172K$171,875: CEO bonus reflected the 2025 retention bonus program.
- $395K$395,313: CEO non-equity incentive compensation paid for 2024 performance was not reported for 2025.
- $667K$667,000: CEO annual base salary approved effective January 1, 2026.
- 55%55%: CEO target annual bonus remains a percentage of annual base salary.
- 100%100%: Change-in-control acceleration applies to service-based equity awards after qualifying termination.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.